INTERPACE BIOSCIENCES, INC. Derivative, Fair Value, Net
INTERPACE BIOSCIENCES, INC. (IDXG) had Derivative, Fair Value, Net of $10.61 million as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeNet · last filed 2023-11-08
- 2023-09-30: Derivative, Fair Value, Net $10.61M.
- 2023-06-30: Derivative, Fair Value, Net $10.77M.
- 2023-03-31: Derivative, Fair Value, Net $10.93M.
- 2022-12-31: Derivative, Fair Value, Net $11.09M.
| Period end | Derivative, Fair Value, Net | Derivative, Fair Value, Net as first filed |
|---|---|---|
| 2023-09-30 | $10.61M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $10.77M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $10.93M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $11.09M 10-Q · filed 2023-11-08 | |
| 2022-09-30 | $11.13M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $11.07M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $9.68M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $9.94M 10-K · filed 2023-03-27 | $9.88M 10-K · filed 2022-03-31 |
| 2021-09-30 | $2.29M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.40M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $2.24M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $2.24M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $2.83M 10-Q · filed 2021-01-20 | |
| 2020-06-30 | $2.89M 10-Q/A · filed 2021-01-19 | |
| 2020-03-31 | $2.92M 10-Q/A · filed 2021-01-19 | |
| 2019-12-31 | $2.98M 10-K · filed 2021-04-01 | |
| 2018-12-31 | $3.49M 10-K/A · filed 2021-01-19 | |
| 2018-03-31 | $1.91M 10-Q · filed 2018-05-15 |